NCT04644159View on ClinicalTrials.gov

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

July 1, 2023

Conditions
SARS (Severe Acute Respiratory Syndrome)Covid19
Interventions
OTHER

Human biological samples

Blood , saliva, nasopharyngeal mucosa

Trial Locations (2)

60800

Hôpital de Crépy en Valois, Crépy-en-Valois

75724

Institut Pasteur, Paris

Sponsors

Lead Sponsor

Institut Pasteur
All Listed Sponsors
lead

Institut Pasteur

INDUSTRY